Healthcare / Health Information ServicesKOSDAQ
$13240.00
-760.00 (-5.43%)
FCF base 3Y
n/d
n/d CAGR · yield n/d
FCF base 5Y
n/d
n/d base · n/d expected
Precio de entrada
n/d
MOS 33% · confianza 24%
FCF escenarios
weak_data · normalized FCF $-13.0B · quality 72.7/100
Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.
SA Score
26/100
D
Piotroski
2/9
balance/quality
Valuation
50/100
+0.0% upside
5Y CAGR
+0.0%
50/100
Data QA
16/100
SEC 0%
Sin guardar todavía.
Market Cap
$160.1B
P/E
N/A
•EV/EBITDA
N/A
•ROE
-115.1%
↓Gross Margin
100.0%
↑Debt/Equity
0.28
↑TradingView lightweight chart
Absolute Values (Left Axis)
Ratios / Percentages (Right Axis)
Financial statement dashboard
2022–2025 · 3 años de histórico normalizado
Revenue CAGR
+59.3%
FCF CAGR
—
FCF margin
-588.6%
FCF / Net income
0.69x
Latest source
Provider fallback
Margin decomposition
Último año: revenue $2.62B · net income $-22.39B · FCF $-15.39B
Gross margin
Operating margin
Net margin
FCF margin
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $2.62B | $2.62B | $2.22B | $1.56B | $647.3M |
| Net Income | $-22.39B | $-22.39B | $-15.10B | $5.26B | $-18.32B |
| EBITDA | $-20.36B | $-20.36B | $-10.39B | $8.58B | $-15.51B |
| EPS | — | — | -4091.00 | -1236.00 | -5081.00 |
| Gross Margin | 100.0% | 100.0% | 100.0% | 91.5% | 102.5% |
| Operating Margin | -632.8% | -632.8% | -661.0% | -753.0% | -1454.6% |
| Net Margin | -856.2% | -856.2% | -681.4% | 336.9% | -2831.1% |
| Balance Sheet | |||||
| Debt/Equity | 0.28 | 0.28 | -0.03 | -0.05 | -0.05 |
| Current Ratio | 8.04 | 8.04 | — | — | — |
| Cash Flow | |||||
| Free Cash Flow | $-15.39B | $-15.39B | $-13.01B | $-9.29B | $-7.66B |
| Returns | |||||
| ROE | -115.1% | -115.1% | 29.5% | -14.4% | 41.9% |
| Valuation | |||||
| P/B | 7.86 | 7.86 | — | — | — |
| Growth & Yield | |||||
| Revenue Growth | 18.0% | 18.0% | 41.9% | 141.4% | — |
| EPS Growth | — | — | -231.0% | 75.7% | — |
Revenue, Net Income & Free Cash Flow ($B)
Margins (%)
Returns (%)
Leverage & Liquidity
Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.
Total return
-34.8%
Start / end P/E
n/dx → n/dx
EPS bridge
-4091.00 → n/d
Residual
-34.8%
EPS/multiple decomposition requires positive EPS at both endpoints; residual absorbs price move not explained by dividends.
Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.